gammaCore, a handheld device used to alleviate cluster headaches, is now availble through NHS England following successful trials.
The roll out of the medical device is supported by the Medtech Funding Mandate, which fast-tracks innovations in the NHS. This mandate is part of the NHS Long Term Plan and came into effect on 1 April 2021.
WHY IT MATTERS
gammaCore works to relieve pain by delivering...
The EU has approved an artificial intelligence (AI) technology that can identify people at risk of a fatal heart attack, years before it strikes.
The CaRi-Heart technology, developed by British Heart Foundation (BFH) spinout company Caristo Diagnostics, utilises coronary CT angiogram (CTTA) scans already performed in clinical practice.
It uses AI and deep-learning technology to produce a fat...
The United Arab Emirates (UAE) has become the first country in the Arab world to begin manufacturing a COVID-19 vaccine with a full production schedule underway.
Hayat-Vax, a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42, was announced earlier this week during the launch of a new purpose-built research and development hub for life sciences, biotechnology and vaccine production in...
Quibim, a global medical imaging analysis specialist, has joined Highlight Therapeutics, a clinical-stage company specialising in immuno-oncology, to assess the efficacy of new immunotherapy treatments in advanced melanoma skin cancer using AI in a Phase II clinical trial in Spain.
The alliance will analyse the information contained in radiological scans and correlate these findings with...
.jpeg?itok=iA1acgtG "Hayat-Vax is a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42. Meanwhile, the country’s COVID-19 contact tracing app will now also function as a national vaccine registry.")
